NCI Cancer Bulletin: A Trusted Source for Cancer Research News
NCI Cancer Bulletin: A Trusted Source for Cancer Research News
April 27, 2004 • Volume 1 / Number 17 E-Mail This Document  |  View PDF Version  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Study Explores Health Benefits and Cost-Effectiveness of HPV Vaccinations and Screening

Director's Update
A Model for Addressing Health Care Disparities

Cancer Research Highlights
Signaling Pathways Controlling c-Myc Degradation Shown to Affect Oncogenic Transformation of Human Cells

Halting of Antitobacco Campaign Increases Youth Smoking Susceptibility

Rituximab Trial Ends Two Years Early

Special Report
Pushing Boundaries with Team Science

A Conversation with
Dr. Daniel C. Sullivan


Funding Opportunities

Featured Clinical Trial
Chemoprevention Trial for Men at High Risk for Prostate Cancer

Notes
June Cancer Survivorship Conference

Additional SPOREs Funding

Updated Nausea and Vomiting Guidelines Released

New Spanish-language Publications Available

Wickner Elected to National Academy of Sciences

Featured Meetings

Bulletin Archive

Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
View/Print PDF  View/Print PDF
Funding Opportunities

Novel Technologies for in vivo Imaging (SBIR/STTR)

PA-04-094
Application Receipt Dates: Dec. 1, 2004;
Apr. 1, 2005; Aug. 1, 2005

NCI and other NIH institutes invite applications for the development and delivery of novel image acquisition or enhancement technology and methods for biomedical imaging and image-guided interventions and therapy. NCI is focused on imaging in vivo for cancer pre-conditions and cancer screening, diagnosis, progression, treatment monitoring, recurrence, and surrogate endpoints. The focus includes the discovery, development, and delivery of cancer-specific imaging technologies, and optimization and validation of imaging technologies for cancer applications. This PA replaces PAR-03-125.

This PA will use the SBIR/STTR award mechanism.

Inquiries: Dr. Guoying Liu, guoyingl@mail.nih.gov; Dr. Keyvan Farahani, farahank@mail.nih.gov; Dr. James A. Deye, deyej@mail.nih.gov; and Dr. Houston Baker, bakerhou@mail.nih.gov

Novel Technologies for in vivo Imaging (R21/R33)

PA-04-095
Application Receipt Date: Jul. 1, 2005

NCI invites applications for the development and delivery of novel image acquisition or enhancement technologies and methods for biomedical imaging and image-guided interventions and therapy that may incorporate limited pilot or clinical feasibility evaluations using either pre-clinical models or clinical studies. This initiative is primarily intended to facilitate technologies for early detection, screening, diagnosis, image-guided interventions, and treatment of various diseases. This PA replaces PAR-03-124.

This PA will use the NIH R33 Exploratory Developmental Phase II Award and the combined R21/R33 Phased-Innovation Award mechanisms. For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2021.

Inquiries: Dr. Guoying Liu, guoyingl@mail.nih.gov; Dr. Keyvan Farahani, farahank@mail.nih.gov; Dr. James A. Deye, deyej@mail.nih.gov; and Dr. Houston Baker, bakerhou@mail.nih.gov

Additional Genotyping for the Human Haplotype Map

RFA-HG-04-005
Letter of Intent Receipt Date: May 28, 2004
Application Receipt Date: Jun. 25, 2004

This RFA solicits applications for a cooperative agreement to augment the International HapMap Project by supporting the genotyping of approximately 2.25 million SNPs across the genome in 270 samples from 4 populations, at high quality and at a cost of about 1 cent per genotype. The data from this effort will contribute to the development of a map, called the HapMap, of the haplotype patterns in the human genome and of a set of SNPs that are informative about these patterns and the associations among the SNPs.

This RFA will use the NIH U54 Specialized Center Cooperative Agreement award mechanism. For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2023.

Inquiries: Dr. Wendy Wang, wangw@mail.nih.gov

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov